Ivermectin, a medication widely used for decades to treat parasitic infections, has recently drawn attention in oncological research. Scientists are investigating whether this well-known drug may influence cellular pathways involved in cancer growth and survival.
Early laboratory studies suggest ivermectin may affect several important signaling pathways associated with tumor development, including those related to cellular metabolism, inflammation, and tumor cell proliferation. Some research has shown that ivermectin may interfere with pathways such as Wnt/β-catenin and PI3K/AKT signaling, both of which are involved in cancer cell growth and survival.
It is important to note that most of this research remains preclinical, meaning the findings have primarily been observed in laboratory models and animal studies. Currently, ivermectin is not an approved treatment for cancer, and more human clinical trials are needed to determine whether these mechanisms translate into meaningful therapeutic outcomes.
However, this research reflects a broader shift happening within the field of oncology. Increasingly, scientists are looking beyond genetic mutations alone and examining how factors such as metabolism, mitochondrial function, inflammation, and immune regulation influence the environment in which cancer develops.
Mitochondria—often referred to as the powerhouses of the cell—play a central role in cellular energy production and metabolic signaling. When mitochondrial function becomes impaired, cells may shift toward less efficient energy pathways and increased oxidative stress. Some researchers believe these metabolic disruptions may contribute to conditions that allow abnormal cells to survive and proliferate.
At the same time, the tumor microenvironment—the network of immune cells, signaling molecules, and surrounding tissues—has become a key focus of cancer research. Chronic inflammation, immune imbalance, and microbial influences are all being studied for their potential roles in shaping this environment.
While no single factor determines whether cancer develops, research consistently points to several foundational elements that support cellular resilience, including healthy metabolism, mitochondrial function, immune balance, and reduced chronic inflammation.
Clinical Areas of Interest: Metabolism, Mitochondria, and Immune Balance
As research continues to explore cancer metabolism and cellular health, many clinicians are also investigating therapies that support these underlying systems.
Several peptide therapies have been studied for their potential roles in supporting metabolic function, mitochondrial efficiency, and immune regulation.
Examples include:
- MOTS-c – A mitochondrial signaling peptide being studied for its potential role in metabolic regulation and cellular energy balance.
- Thymosin Alpha1 – Known for its role in immune system modulation and T-cell support.
- Epitalon – Investigated for its potential influence on cellular aging and telomere activity.
- Elamipretide – Designed to interact with mitochondrial membranes and support mitochondrial function.
While these therapies remain areas of active research, they reflect a growing interest in supporting metabolic health, mitochondrial function, and immune balance as part of a broader approach to long-term wellness and disease prevention.
References
- Ivermectin as an Alternative Anticancer Agent: A Review of Its Potential Mechanisms and Applications. National Library of Medicine / PubMed Central https://pmc.ncbi.nlm.nih.gov/articles/PMC12566834/
- Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation. Science. 2009.
- Wallace DC. Mitochondria and Cancer. Nature Reviews Cancer. 2012.
- Pantziarka P, et al. Repurposing Drugs in Oncology. ecancermedicalscience. 2018.
Learn More
Providers interested in exploring the science behind cancer metabolism and mitochondrial biology can review additional resources at:
National Cancer Institute – Cancer Metabolism Research
https://www.cancer.gov/research/areas/basic-research/metabolism
PubMed Central – Biomedical Research Library
https://www.ncbi.nlm.nih.gov/pmc/
National Institutes of Health – Mitochondrial Biology Overview
https://www.nigms.nih.gov/education/fact-sheets/Pages/mitochondria.aspx
Interested in Expanding Your Therapeutic Toolkit?
If you are looking for a streamlined online eRx platform to order peptides, hormones, GLP-1 therapies, and other integrative treatments, MyPracticeConnect makes it easy to connect with trusted pharmacy partners and manage prescriptions through one platform.
�� Learn more or book a demo here.
www.mypracticeconnect.com
